TTRX Initiated Coverage On by Lucid Capital Markets -- Rating Set to Buy

As reported by gurufocus.com

On September 24, 2026, Turn Therapeutics Inc TTRX caught the attention of investors as Lucid Capital Markets initiated coverage on the stock with a "Buy" rating...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on gurufocus.com ↗

Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.

INDIAN SEBI opens wider commodity derivatives market to foreign portfolio investors mint - markets
INDIAN Listing lesson: NSE debut shows why mega-IPOs can disappoint despite high demand mint - markets
INDIAN Sebi board allows FPI access in non-farm goods, approves revamp of PMS, settlement rules mint - markets
INDIAN NSE debut boosts BSE's cash market turnover mint - markets
INDIAN US stock market LIVE updates: Nasdaq, S&P open lower amid surging Treasury yields; Oracle shares crash 5% mint - markets
INDIAN Nifty hits over five-month low as banks, NBFCs slide amid high oil prices Share Market Today
INDIAN Sebi approves reforms to PMS regulations, settlement proceedings Share Market Today
INDIAN H2FY27 hiring intent seen at 5.4%, e-commerce leads growth: Report Share Market Today

TTRX Initiated Coverage On by Lucid Capital Markets -- Rating Set to Buy

More from Market Samachar